- CH₣311.46bn
- CH₣337.55bn
- CH₣61.52bn
BioNTech on track for worst day since March after ending colorectal cancer trial
BioNTech falls after terminating colorectal cancer trial
BioNTech halts mRNA colorectal cancer vaccine trial after safety review (updated)
Duality Biotherapeutics rises most in near six weeks on Roche's Genentech tie-up
Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance
Brief: Genentech Announces Manufacturing Expansion In Hillsboro, Oregon
Table: Swiss trade surplus at CHF 8.73 bln in July
Analysis: Moderna, Merck breakthrough could usher in wave of cancer vaccines
Factbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine
Brief: Roche Canada & PCPA Complete Negotiations For Perjeta For Neoadjuvant Treatment Of Early Stage Breast Cancer
Drugmakers curb Swiss reimbursement applications over US pricing concerns
Factbox: Global drugmakers invest billions to boost US presence
C4 Therapeutics rises after quarterly revenue beat
Factbox: Global drugmakers invest billions to boost US presence
Bristol Myers to build $2.3 billion manufacturing site in Houston
Roche launches two new cyclospora tests as US outbreak widens
Roche sues Biocon over proposed breast-cancer drug copy (updated)
Roche sues Biocon over proposed breast-cancer drug copy
Sika raises annual sales-growth outlook after strong first-half performance (updated)